-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – interferon gamma-1b in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - interferon gamma-1b in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Interferon gamma-1b in Non-Small Cell Lung Cancer Drug...
-
Company Profile
Vaxcyte Inc – Company Profile
Vaxcyte Inc (Vaxcyte), formerly SutroVax Inc, is a clinical-stage vaccine innovation company. It develops novel vaccines to prevent and treat infectious diseases. The company's pipeline products include VAX-24, an invasive pneumococcal disease (IPD); VAX-XP, a superior conjugate vaccine against IPD; VAX-A1, group A strep infections in children; and VAX-PG, a novel protein vaccine, targeting periodontitis in adults. It utilizes a cell-free protein synthesis platform to design and produce protein carriers and antigens, the critical building blocks of vaccines. The company...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – VAX-24
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry VAX-24 Drug Details VAX-24 is under development for the prevention of Streptococcus pneumonia infections...
-
Product Insights
Impetigo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Impetigo symptoms include fluid-filled blisters, itchy rash, skin lesions, and swollen lymph nodes. The Impetigo pipeline drugs market research report provides comprehensive information on the therapeutics under development for Impetigo (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report reviews...
-
Product Insights
Otitis Media Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Otitis media (OM) is any inflammation of the middle ear, the air-filled space behind the eardrum that contains the tiny vibrating bones of the ear. Symptoms include ear pain, difficulty sleeping, loss of balance, fever, headache, and loss of appetite. Risk factors include age, seasonal factors, and exposure to tobacco smoke or high levels of air pollution. Treatment includes antibiotics and antipyrine. The otitis media drugs in development market research report provides an overview of the Otitis Media pipeline landscape....